Aratana Therapeutics
company
About
Aratana Therapeutics develops innovative therapies for the animal health industry.
- 51 - 100
Highlights
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $12M
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2010
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Aratana is uniquely positioned to deliver new, high-quality medicines to address unmet needs in companion animal care. We are committed to bringing world class science to animal health for companion animals and the people who care for them. Our competitive advantage resides in our ability to identify, acquire and develop high-value commercial products for companion animals in a cost effective and efficient manner.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$12M
Aratana Therapeutics has raised a total of
$12M
in funding over 2 rounds. Their latest funding was raised on
Jan 31, 2013 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 31, 2013 | Series C | $12M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Aratana Therapeutics is funded by 2 investors.
Midwest Venture Alliance
and Women's Capital Connection
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Midwest Venture Alliance
|
— | Series C |
Women's Capital Connection
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
